ATHENA data op CROI 2019
Virologic and immunologic outcomes of integrase inhibitors (INSTIs) in RESPOND
Neesgaard B, Mocroft A, Zangerle R, Wit F , Youle M, Lampe F, Günthard H, Braun D, Necsoi C, De wit S, Law M, Petomenos K, Mussini C, Vincenzo S, Castagna A, d’Arminio Monforte A, Pradier C, Chkhartishvilli N, Tsertsvadza T, Reyes-Urueña J, Vehreschild JJ, Wasmuth JC, Stephan C, Llibre JM, Peters L, Pelchen-Matthews A, Vannappagari V, Gallant J, Greenberg L, Lundgren JD and Ryom Lon behalf of the RESPOND study group.
CROI 2019: Conference on Retroviruses and Opportunistic Infections, Boston, USA, 4-7 March 2019
Impact and determinants of comorbidity clusters in people living with HIV
De Francesco D, Verboeket SO, Underwood J, Wit FW, Bagkeris E, Mallon PWG, Winston A, Reiss P and Sabin CA for the POPPY study group
CROI 2019: Conference on Retroviruses and Opportunistic Infections, Boston, USA, 4-7 March 2019
Variability in cognitive impairment over time in people with hiv and matched controls
De Francesco D, Sabin CA , Underwood J, Gisslen M, Wit FW, van Zoest RA, Schouten J, Geurtsen G, Schmand B, Portegies P, Reiss P and Winston A for the Co-morBidity in Relation to AIDS (COBRA) collaboration
CROI 2019: Conference on Retroviruses and Opportunistic Infections, Boston, USA, 4-7 March 2019
Cognitive development in perinatally HIV-infected children on long-term treatment compared to healthy matched controls: a longitudinal cohort study
Van den Hof M, ter Haar AM, Scherpbier J, van der Lee JH, Reiss P, Wit FWNM, Oostrom KJ, Pajkrt D
CROI 2019: Conference on Retroviruses and Opportunistic Infections, Boston, USA, 4-7 March 2019
HIV infection and risk of recurrent venous thromboembolism: a national cohort study
Rokx C, Borjas Howard J, Smit C, Wit F, Pieterman ED, Cannegieter S, Lijfering W, Meijer K, Reiss P, Bierman W, Tichelaar V, Rijders B
CROI 2019: Conference on Retroviruses and Opportunistic Infections, Boston, USA, 4-7 March 2019